Melanoma Metastasized to the Brain and Steroids

Clinical trial NCT03563729 · RECRUITING

Trial details

NCT number: NCT03563729
Sponsor: Inge Marie Svane
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2018-06-06
Primary completion: 2024-06-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.